These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30765607)

  • 1. Parallel adaptation of rabbit populations to myxoma virus.
    Alves JM; Carneiro M; Cheng JY; Lemos de Matos A; Rahman MM; Loog L; Campos PF; Wales N; Eriksson A; Manica A; Strive T; Graham SC; Afonso S; Bell DJ; Belmont L; Day JP; Fuller SJ; Marchandeau S; Palmer WJ; Queney G; Surridge AK; Vieira FG; McFadden G; Nielsen R; Gilbert MTP; Esteves PJ; Ferrand N; Jiggins FM
    Science; 2019 Mar; 363(6433):1319-1326. PubMed ID: 30765607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxoma virus in rabbits.
    Kerr PJ; Best SM
    Rev Sci Tech; 1998 Apr; 17(1):256-68. PubMed ID: 9638815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of genetic resistance to myxomatosis in wild rabbits in Britain.
    Ross J; Sanders MF
    J Hyg (Lond); 1984 Jun; 92(3):255-61. PubMed ID: 6736637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.
    Best SM; Kerr PJ
    Virology; 2000 Feb; 267(1):36-48. PubMed ID: 10648181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myxomatosis: rabbits have separately developed the same mechanisms of genetic resistance in France, Australia and the United Kingdom].
    Marchandeau S; Queney G; Alves JM; Carneiro M; Ferrand N
    Med Sci (Paris); 2019; 35(8-9):611-613. PubMed ID: 31532367
    [No Abstract]   [Full Text] [Related]  

  • 6. Myxomatosis in Australia and Europe: a model for emerging infectious diseases.
    Kerr PJ
    Antiviral Res; 2012 Mar; 93(3):387-415. PubMed ID: 22333483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxomatosis: the virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis.
    Edmonds JW; Nolan IF; Shepherd RC; Gocs A
    J Hyg (Lond); 1975 Jun; 74(3):417-8. PubMed ID: 1056963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible interaction between myxomatosis and calicivirosis related to rabbit haemorrhagic disease affecting the European rabbit.
    Marchandeau S; Bertagnoli S; Peralta B; Boucraut-Baralon C; Letty J; Reitz F
    Vet Rec; 2004 Nov; 155(19):589-92. PubMed ID: 15573951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to myxoma virus.
    Kerr P; McFadden G
    Viral Immunol; 2002; 15(2):229-46. PubMed ID: 12081009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
    Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
    Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host.
    Stanford MM; Werden SJ; McFadden G
    Vet Res; 2007; 38(2):299-318. PubMed ID: 17296158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluctuations in the titre of antibody to a soluble antigen of myxoma virus in field populations of rabbits, Oryctolagus cuniculus (L.), in Australia.
    Williams RT; Dunsmore JD; Sobey WR
    J Hyg (Lond); 1973 Sep; 71(3):487-500. PubMed ID: 4518348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the virulence of myxoma virus strains in Britain.
    Ross J; Sanders MF
    Epidemiol Infect; 1987 Feb; 98(1):113-7. PubMed ID: 3556434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying resistance to myxomatosis in wild rabbits produces novel evolutionary insights.
    Cooke BD; Taggart P; Patel K
    Epidemiol Infect; 2023 Oct; 151():e182. PubMed ID: 37823321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coccidian and nematode infections influence prevalence of antibody to myxoma and rabbit hemorrhagic disease viruses in European rabbits.
    Bertó-Moran A; Pacios I; Serrano E; Moreno S; Rouco C
    J Wildl Dis; 2013 Jan; 49(1):10-7. PubMed ID: 23307367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Evolutionary Pathways of Myxoma Virus in Australia: Virulence Phenotypes in Susceptible and Partially Resistant Rabbits Indicate Possible Selection for Transmissibility.
    Kerr PJ; Cattadori IM; Sim D; Liu J; Holmes EC; Read AF
    J Virol; 2022 Oct; 96(20):e0088622. PubMed ID: 36197107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits.
    Best SM; Collins SV; Kerr PJ
    Virology; 2000 Nov; 277(1):76-91. PubMed ID: 11062038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoma virus and the Leporipoxviruses: an evolutionary paradigm.
    Kerr PJ; Liu J; Cattadori I; Ghedin E; Read AF; Holmes EC
    Viruses; 2015 Mar; 7(3):1020-61. PubMed ID: 25757062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.